Pharmacologically, LCL16 knocked down both cIAP1 and cIAP2 to sensitize tumor to paclitaxel-induced cell death in colon cancer and specific antagonist inhibiting cIAP1 were potent to cause TNF-α-induced apoptosis in an autocrine way [29,30]. Here, BIRC2 is linked to colonic neoplasm.